Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 72

Results For "testing"

740 News Found

Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test
Drug Approval | August 30, 2021

Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test

The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit


Regimen launches world’s first personalised digital therapy for ED
Startup | August 25, 2021

Regimen launches world’s first personalised digital therapy for ED

The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe


Govt to offer incentives to support 75 start-ups in Tele-Medicine, AI and Digital Health
Startup | August 25, 2021

Govt to offer incentives to support 75 start-ups in Tele-Medicine, AI and Digital Health

The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge


Lasa Super Generics open for business
News | August 24, 2021

Lasa Super Generics open for business

Floods had forced the plans in Mahad to shut down


Delfi liquid biopsy shows promise for reducing lung cancer deaths
Biotech | August 23, 2021

Delfi liquid biopsy shows promise for reducing lung cancer deaths

When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers


Covid-19 severity screening method developed
Digitisation | August 23, 2021

Covid-19 severity screening method developed

Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer


Enzene Biosciences obtains DCGI approval for Romiplostim biosimilar
Biotech | August 20, 2021

Enzene Biosciences obtains DCGI approval for Romiplostim biosimilar

It is the only biopharmaceutical company in India to offer all three dosage strengths of the drug (125mcg, 250mcg, and 500mcg)


Second-Gen mRNA COVID-19 vaccine candidate CV2CoV show positive signs in preclinical study
Biotech | August 19, 2021

Second-Gen mRNA COVID-19 vaccine candidate CV2CoV show positive signs in preclinical study

The preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone jointly developed by CureVac and GSK compared to CureVac’s first-generation mRNA backbone


FDA grants Emergency Use Authorization for next-generation Covid-19 assays
Digitisation | August 19, 2021

FDA grants Emergency Use Authorization for next-generation Covid-19 assays

Thermo Fisher’s kits leverage an updated design from the original TaqPath assays, targeting eight different genes across three regions of the virus that causes Covid-19


India restricts export of Rapid Antigen Test Kits used to detect Covid 19
Policy | August 16, 2021

India restricts export of Rapid Antigen Test Kits used to detect Covid 19

The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT